 |
|
|
|
|
Novacea is committed to becoming a world-class biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of life-threatening diseases. Novacea's current product platform focuses on anti-cancer compounds for patients with few treatment options. In our pursuit of advancing patient care, Novacea adheres to the highest standards of integrity and scientific excellence.
With expertise in licensing, clinical research, development and commercialization of oncology products, Novacea's seasoned management team is experienced and qualified to develop products that have the potential to improve the lives of patients. Employing an in-licensing business model, the company seeks to create alliances with industry and academia through acquiring access to promising products in an effort to make Novacea a leading oncology company.
|
|
|
|
|
|
|
|
